Chukwueme Onwuzuruigbo MD in South Setauket, New York

Home New York South Setauket

Chukwueme Onwuzuruigbo MD has General Surgery as his primary medical specialty. Their primary office is: 3771 Nesconset Hwy in South Setauket, New York. They attended Sorry, his university is not listed and graduated in 1986 (around 38 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Chukwueme J Onwuzuruigbo MD Office Phone and Directions

Chukwueme Onwuzuruigbo MD
3771 Nesconset Hwy
South Setauket, New York 11720
631-689-5384

Patient Ratings
Please rate your experience with Chukwueme Onwuzuruigbo MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 631-689-5384

Enter a starting address:

Healthcare Info for Chukwueme Onwuzuruigbo MD

Additional Medical Specialties Include:
THORACIC SURGERY

Medical School: Sorry, his university is not listed
Graduation Year: 1986
The Primary Medical Specialty for Chukwueme Onwuzuruigbo MD is listed as: General Surgery
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 38
PAC (PECOS ID)#: 9032168745
NPI #: 1760582746
NPI Created On: 09/22/2006
NPI Last Updated Listed as: 02/07/2008
Primary Taxonomy Code: 208600000X
License Number:
221837
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $118

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 806842149

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: TETRACYCLINE CLASS ANTIBACTERIAL

Name of Drug #1: XERAVA

Open Associated Drug #1: 71773-050-12